Fabry Disease Treatment Market size is projected to experience significant growth from 2021 to 2027. Fabry disease is a rare acquired lysosome stockpile problem caused by genetic modifications that interfere with the dose of the alpha-galactosidase protein. Most Fabry diseases start with mild symptoms and start late, so a few patients are not found often. The […]
